STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
STAAR Surgical Company (NASDAQ: STAA) announced the appointment of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel to drive innovation and growth. Nancy brings extensive experience from Johnson & Johnson, while Nate joins from NuVasive. This move reflects the company's commitment to enhancing brand awareness and legal functions globally. The new executives will play a vital role in accelerating growth and expanding the market for the EVO family of Implantable Collamer Lenses.
Appointment of experienced executives with proven track records to drive growth and innovation.
Enhancing brand awareness and global marketing efforts to grow the market for surgeon customers.
Strong addition to the leadership team with the appointment of a Chief Marketing Officer and General Counsel.
The retirement of the former General Counsel after 12 years of service may pose a transition challenge.
There may be initial adjustment periods needed for the new executives to fully integrate into the company's culture and operations.
New Appointments Underscore Commitment to Driving Innovation and Industry-Leading Growth
Nancy Sabin, Chief Marketing Officer, STAAR Surgical (Photo: Business Wire)
“We are thrilled to strengthen the STAAR team with the addition of Nancy and Nate, two seasoned executives with extensive senior leadership experience. They will play an integral role in accelerating our momentum and thereby growing the market for our surgeon customers who provide patients visual freedom from contact lenses and glasses with our lens-based technology,” said Tom Frinzi, President and CEO of STAAR Surgical. “Nancy is a perfect fit for the newly created Chief Marketing Officer position and will be critical to driving our brand awareness and innovation globally. She is a proven commercial leader with an extensive track record of delivering growth within consumer products, OTC pharmaceuticals and medical devices during her 20-year career with various franchises at Johnson & Johnson. Nate takes on an important role as our new General Counsel overseeing our legal functions globally. Nate brings to STAAR extensive experience providing legal advice and counsel to public companies, including 15 years in med-tech. He joins us from NuVasive where he was instrumental in its successful
Frinzi continued, “I would like to express my utmost gratitude to Sam Gesten, STAAR’s former general counsel, who retired after 12 years of service earlier this year. We are grateful for his tireless work in moving the company forward and wish him all the very best in the future.”
Nancy Sabin joined the team from Johnson & Johnson (J&J) where she most recently served as VP of Marketing and Connected Commerce for J&J Vision managing based marketing, digital strategy and connected commerce functions for the ACUVUE™ contact lens business in the
Ms. Sabin stated, “I am delighted to be a part of STAAR during this critical phase in the company's growth. I am a huge believer in the transformation made possible thanks to our EVO ICLs and look forward to elevating the STAAR and EVO brands among surgeons and their patients. I am excited and honored to lead our marketing teams worldwide.”
Nathaniel Sisitsky joined STAAR Surgical from NuVasive, Inc., a medical device company, where he served as Senior Vice President, General Counsel and Corporate Secretary since 2018. Prior to joining NuVasive, he served as Vice President and Associate General Counsel at CareFusion Corporation, a global medical technology company, and as Vice President, Legal – Corporate Finance at American Tower Corporation, a global owner and operator of wireless communication sites. Prior to joining American Tower, Nate was a Junior Partner in the Corporate Department of Wilmer Cutler Pickering Hale and Dorr (WilmerHale). He holds a J.D. from New York University School of Law and a B.A. in Political Science and Economics from Emory University.
“I am thrilled to join the STAAR leadership team at a time of significant opportunity and growth for our vision correction lenses,” said Nate Sisitsky.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™ product line. More than 3,000,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240501408389/en/
Investors & Media
Brian Moore
Vice President, Investor Relations and Corporate Development
(626) 303-7902, Ext. 3023
bmoore@staar.com
Source: STAAR Surgical Company
FAQ
Who are the new appointments at STAAR Surgical Company?
What is the stock symbol for STAAR Surgical Company?
Where is STAAR Surgical Company headquartered?
What is the main product line of STAAR Surgical Company?
How many ICLs have been sold by STAAR Surgical Company?
What is the website for more information on the EVO ICL product line?
